ZA811733B - A pharmaceutical formulation of a vinca dimer - Google Patents

A pharmaceutical formulation of a vinca dimer

Info

Publication number
ZA811733B
ZA811733B ZA00811733A ZA811733A ZA811733B ZA 811733 B ZA811733 B ZA 811733B ZA 00811733 A ZA00811733 A ZA 00811733A ZA 811733 A ZA811733 A ZA 811733A ZA 811733 B ZA811733 B ZA 811733B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
vinca dimer
vinca
dimer
formulation
Prior art date
Application number
ZA00811733A
Other languages
English (en)
Inventor
Miller Jean Corinne
Jean Corinne Miller
Gutowski Gerald Edward
Gerald Edward Gutowski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA811733B publication Critical patent/ZA811733B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA00811733A 1980-03-20 1981-03-16 A pharmaceutical formulation of a vinca dimer ZA811733B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/132,246 US4357334A (en) 1980-03-20 1980-03-20 Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms

Publications (1)

Publication Number Publication Date
ZA811733B true ZA811733B (en) 1982-10-27

Family

ID=22453135

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00811733A ZA811733B (en) 1980-03-20 1981-03-16 A pharmaceutical formulation of a vinca dimer

Country Status (28)

Country Link
US (1) US4357334A (xx)
EP (1) EP0036762B1 (xx)
JP (1) JPS56145293A (xx)
KR (1) KR840002146B1 (xx)
AR (1) AR228863A1 (xx)
AT (1) ATE9761T1 (xx)
AU (1) AU539564B2 (xx)
BG (1) BG36200A3 (xx)
CA (1) CA1159055A (xx)
DD (1) DD157558A5 (xx)
DE (1) DE3166544D1 (xx)
DK (1) DK124281A (xx)
EG (1) EG15247A (xx)
ES (2) ES500536A0 (xx)
FI (1) FI810856L (xx)
GB (1) GB2072184B (xx)
GR (1) GR73870B (xx)
HU (1) HU185247B (xx)
IE (1) IE51034B1 (xx)
IL (1) IL62378A (xx)
NZ (1) NZ196511A (xx)
PH (1) PH16213A (xx)
PL (1) PL230226A1 (xx)
PT (1) PT72695B (xx)
RO (2) RO85813B (xx)
SU (2) SU1017172A3 (xx)
YU (1) YU66281A (xx)
ZA (1) ZA811733B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR81790B (xx) * 1983-04-29 1984-12-12 Omnichem Sa
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204004A1 (es) 1973-04-02 1975-11-12 Lilly Co Eli Procedimientos para preparar derivados de vinblastina leurosidina y leurocristina
IL48685A (en) 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (xx) 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4160767A (en) * 1976-12-06 1979-07-10 Eli Lilly And Company Vinca alkaloid intermediates
US4191688A (en) * 1977-08-08 1980-03-04 Eli Lilly And Company Amides of leurosine, leuroformine, desacetylleurosine and desacetylleuroformine
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids

Also Published As

Publication number Publication date
GB2072184B (en) 1984-01-11
ES8302009A1 (es) 1982-12-16
RO82171A (ro) 1983-07-07
IL62378A (en) 1984-03-30
ATE9761T1 (de) 1984-10-15
DK124281A (da) 1981-09-21
DD157558A5 (de) 1982-11-17
AU6858181A (en) 1981-09-24
ES8206538A1 (es) 1982-08-16
EG15247A (en) 1986-03-31
PT72695B (en) 1982-03-24
FI810856L (fi) 1981-09-21
KR840002146B1 (ko) 1984-11-23
US4357334A (en) 1982-11-02
AU539564B2 (en) 1984-10-04
ES509581A0 (es) 1982-12-16
EP0036762B1 (en) 1984-10-10
RO85813B (ro) 1984-11-30
NZ196511A (en) 1983-09-30
PH16213A (en) 1983-08-05
GB2072184A (en) 1981-09-30
HU185247B (en) 1984-12-28
GR73870B (xx) 1984-05-09
SU1200851A3 (ru) 1985-12-23
EP0036762A2 (en) 1981-09-30
BG36200A3 (en) 1984-09-14
IL62378A0 (en) 1981-05-20
YU66281A (en) 1983-10-31
DE3166544D1 (en) 1984-11-15
AR228863A1 (es) 1983-04-29
PL230226A1 (xx) 1982-03-15
RO85813A (ro) 1984-11-25
ES500536A0 (es) 1982-08-16
KR830005248A (ko) 1983-08-03
IE810609L (en) 1981-09-20
CA1159055A (en) 1983-12-20
PT72695A (en) 1981-04-01
SU1017172A3 (ru) 1983-05-07
IE51034B1 (en) 1986-09-17
JPS56145293A (en) 1981-11-11
RO82171B (ro) 1983-06-30
EP0036762A3 (en) 1981-10-07

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
DE3273153D1 (en) Pharmaceutical mixture
ZA828797B (en) Pharmaceutical formulation
DE3264782D1 (en) Medicinal formulation
DE3165444D1 (en) C-beta-d-xylopyranoside series compounds and pharmaceutical compositions containing them
IL67336A0 (en) Pharmaceutical composition containing vitamin a
NZ191102A (en) Pharmaceutical formulations of galactomannan
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
GB2087236B (en) Pharmaceutical preparations containing a 6b-halopenicillanic acid
ZA817796B (en) Use of anticholenergic drugs
PH18595A (en) Acylamino qunazoline derivatives and a pharmaceutical composition containing them
ZA818221B (en) Pharmaceutical compounds
DE3166544D1 (en) A pharmaceutical formulation of a vinca dimer
HK43087A (en) Stable pharmaceutical solutions of vinca alkaloids
ZA791759B (en) Monosubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
NZ196244A (en) Indane derivatives and pharmaceutical compositions
SG62587G (en) Pharmaceutical formulation
NZ197416A (en) Penicillin derivatives and pharmaceutical compositions
PT73226B (en) Pharmaceutical bicyclic compounds and compositions
JPS56154487A (en) Manufacture of vinca dimer
JPS56154488A (en) Manufacture of vinca dimer
ZA81919B (en) Pharmaceutical compositions containing a naphyridine derivative
JPS57188596A (en) Manufacture of vinca dimer
IL51937A0 (en) Pharmaceutical compositions containing a penicillin and their preparation
KE3581A (en) Pharmaceutical formulation